These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1306646)

  • 21. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of single versus double volume exchange transfusion in newborn infants with AB0 hemolytic disease.
    Amato M; Blumberg A; Hermann U; Zurbrügg R
    Helv Paediatr Acta; 1988 Nov; 43(3):177-86. PubMed ID: 3220789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemolytic anemia caused by non-D minor blood incompatibilities in a newborn.
    Tugcu AU; Ince DA; Turan O; Belen B; Olcay L; Ecevit A
    Pan Afr Med J; 2019; 33():262. PubMed ID: 31692740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulins in rhesus hemolytic disease.
    Mukhopadhyay K; Murki S; Narang A; Dutta S
    Indian J Pediatr; 2003 Sep; 70(9):697-9. PubMed ID: 14620183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin therapy in neonatal immune hemolytic jaundice.
    Ergaz Z; Arad I
    J Perinat Med; 1993; 21(3):183-7. PubMed ID: 8229608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.
    Girish G; Chawla D; Agarwal R; Paul VK; Deorari AK
    Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Icterus gravis and exchange transfusion].
    Tulzer W; Griebler T
    Wien Med Wochenschr; 1967 Apr; 117(13):334-7. PubMed ID: 4968441
    [No Abstract]   [Full Text] [Related]  

  • 30. Donor blood glucose 6-phosphate dehydrogenase deficiency reduces the efficacy of exchange transfusion in neonatal hyperbilirubinemia.
    Samanta S; Kumar P; Kishore SS; Garewal G; Narang A
    Pediatrics; 2009 Jan; 123(1):e96-e100. PubMed ID: 19103674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
    Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Phototherapy and treatment with phenobarbital in hemolytic disease of newborn due to Rh-incompatibility].
    Menzel K; Schambach K; Töpke B
    Acta Paediatr Acad Sci Hung; 1974; 15(3-4):333-9. PubMed ID: 4219868
    [No Abstract]   [Full Text] [Related]  

  • 33. Exchange transfusion in the neonate: a controlled study using frozen-stored erythrocytes resuspended in plasma.
    Grajwer LA; Pildes RS; Zarif M; Ainis H; Agrawal BL; Patel A
    Am J Clin Pathol; 1976 Jul; 66(1):117-21. PubMed ID: 945688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboxyhemoglobin levels in neonatal immune hemolytic jaundice treated with intravenous gammaglobulin.
    Ergaz Z; Gross D; Bar-Oz B; Peleg O; Arad I
    Vox Sang; 1995; 69(2):95-9. PubMed ID: 8585207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh hemolytic disease.
    Alonso JG; Decaro J; Marrero A; Lavalle E; Martell M; Cuadro JC
    J Perinat Med; 1994; 22(5):415-9. PubMed ID: 7791017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
    Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
    Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Rh-Hemolytic Disease in Neonates and Management with Early Intensive Phototherapy in the Neonatal Intensive Care Unit.
    Tewari VV; Kumar A; Singhal A; Pillai N; Prakash A; Varghese J; Kannan V
    J Trop Pediatr; 2020 Feb; 66(1):75-84. PubMed ID: 31199484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
    Senterre T; Minon JM; Rigo J
    Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of neonatal Rh disease.
    Peterec SM
    Clin Perinatol; 1995 Sep; 22(3):561-92. PubMed ID: 8521682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A trial with high-dose gamma globulin therapy in 3 children with hyperbilirubinemia in rhesus incompatibility].
    Rübo J; Wahn V
    Monatsschr Kinderheilkd; 1990 Apr; 138(4):216-20. PubMed ID: 2355928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.